Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
Copyright policy )Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
Pancreatic cancer (PanCa) is one of the leading causes of death from cancer in the United States. The current standard treatment for pancreatic cancer is gemcitabine, but its success is poor due to the emergence of drug resistance. Natural products have been widely investigated as potential candidates in cancer therapies, and cucurbitacin D (Cuc D) has shown excellent anticancer properties in various models. However, there is no report on the therapeutic effect of Cuc D in PanCa. In the present study, we investigated the effects of the Cuc D on PanCa cells in vitro and in vivo. Cuc D inhibited the viability of PanCa cells in a dose and time dependent manner, as evident by MTS assays. Furthermore, Cuc D treatment suppressed the colony formation, arrest cell cycle, and decreased the invasion and migration of PanCa cells. Notably, our findings suggest that mucin 13 (MUC13) is down-regulated upon Cuc D treatment, as demonstrated by Western blot and qPCR analyses. Furthermore, we report that the treatment with Cuc D restores miR-145 expression in PanCa cells/tissues. Cuc D treatment suppresses the proliferation of gemcitabine resistant PanCa cells and inhibits RRM1/2 expression. Treatment with Cuc D effectively inhibited the growth of xenograft tumors. Taken together, Cuc D could be utilized as a novel therapeutic agents for the treatment/sensitization of PanCa.
- North Dakota State University United States
- The University of Texas at Austin United States
- Jamia Millia Islamia India
- UNIVERSITY OF TEXAS RIO GRANDE VALLEY
- University of Tennessee Health Science Center United States
Models, Molecular, cucurbitacin D, pancreatic cancer, Apoptosis, Deoxycytidine, Article, Mice, Structure-Activity Relationship, mucin, Cell Movement, Cell Line, Tumor, Animals, Humans, Cell Proliferation, cucurbitacin d, QH573-671, Cell Cycle, Mucins, miR-145 and MUC13, Antineoplastic Agents, Phytogenic, Xenograft Model Antitumor Assays, Gemcitabine, Triterpenes, mir-145 and muc13, Pancreatic Neoplasms, Disease Models, Animal, Gene Expression Regulation, Drug Resistance, Neoplasm, Cytology
Models, Molecular, cucurbitacin D, pancreatic cancer, Apoptosis, Deoxycytidine, Article, Mice, Structure-Activity Relationship, mucin, Cell Movement, Cell Line, Tumor, Animals, Humans, Cell Proliferation, cucurbitacin d, QH573-671, Cell Cycle, Mucins, miR-145 and MUC13, Antineoplastic Agents, Phytogenic, Xenograft Model Antitumor Assays, Gemcitabine, Triterpenes, mir-145 and muc13, Pancreatic Neoplasms, Disease Models, Animal, Gene Expression Regulation, Drug Resistance, Neoplasm, Cytology
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!